Skip to content

Vaginal discharge

Print as a PDF

Overview

  • The most common cause of vaginal discharge in people of reproductive age is normal physiological discharge
  • Exclude other causes with history, examination and investigations

Symptoms

Considerations

Discharge

Physiological: white and clear, non-offensive, varying with menstrual cycle (ectropion may be mucoid)
Bacterial vaginosis: thin, grey-white, offensive and fishy odour
Candidiasis: thick, white, non-offensive
Chlamydia and M. genitalium: minimal discharge or purulent (cervicitis)
Gonorrhoea: purulent (cervicitis)
Trichomoniasis: offensive green and yellow, scanty to profuse and frothy (vaginitis)

Bleeding – intermenstrual or postcoital

Chlamydia, M. genitalium, gonorrhoea, cervical ectropion or polyps, malignancy, vaginitis
Presence can suggest cervicitis or pelvic inflammatory disease (PID)

Itch

Candidiasis, trichomoniasis, vulvovaginal dermatitis

Superficial dyspareunia

Candidiasis, dermatitis, lichen planus, lichen sclerosus

Deep dyspareunia

Chlamydia, gonorrhoea, M. genitalium, trichomoniasis.
Presence can suggest PID

Lower abdominal pain

Chlamydia, gonorrhoea, M. genitalium, trichomoniasis.
Presence suggests upper genital tract infection.

Dysuria

Chlamydia, trichomoniasis, candidiasis, herpes and dermatitis can present with external dysuria, fissuring
Presence can also suggest gonorrhoea

Systemic symptoms

Presence of systemic symptoms such as fever and tachycardia indicates upper genital tract infection and PID

Associated factors

Bacterial vaginosis: unclear
Candidiasis: spontaneous, recent antibiotics, pregnancy, immunosuppression
Chlamydia: age < 30 years, new partner or > 1 partner in 12 months preceding, known contact
Gonorrhoea: age < 30 years, new partner or > 1 partner in 12 months preceding, known contact, co-infection with other pathogen; high-risk population (e.g. Aboriginal and Torres Strait Island people in remote community)
M. genitalium: age < 30 years, new partner or > 1 partner in 12 months preceding, known contact
Trichomoniasis: new partner, patient or partner from high-prevalence population
Dermatitis: irritants, eczema

Take a history and perform a physical examination, including inspection of external genitalia, speculum examination of cervix and vagina, and bimanual palpation. Specifically examine for signs: characteristics of discharge (colour, consistency, distribution, volume and odour), cervicitis, vaginitis, vulvitis, ulceration, upper genital tract infection – PID). Clinician-collected samples are preferred but self-collected samples may be considered if the patient declines examination

Site/specimen

Test

Consideration

High vaginal swab
OR
Self-collected vaginal swab

Bacterial vaginosis:
-microscopy and gram stain
-Whiff test (odour during examination indicates a positive whiff test)
– pH test (pH > 4.5 indicative of bacterial vaginosis)
Candidiasis: microscopy and culture

Microscopy and gram stain
Whiff test (odour during examination indicates a positive whiff test)
pH test (pH > 4.5 indicative of bacterial vaginosis)

Endocervical swab
OR
Self-collected vaginal swab
OR
FPU

NAAT test: N. gonorrhoeae, C. trachomatis

Endocervical swab, if speculum examination is indicated, or self-collected vaginal swab is the most sensitive

High vaginal swab
OR
Self-collected vaginal swab
OR
First pass urine (FPU)

NAAT test: trichomonas

Vaginal swab is the most sensitive

NAAT – Nucleic acid amplification test

Specimen collection guidance

Clinician collected | Self-collection

Special considerations

  • Perform cervical screening if overdue. Human papillomavirus (HPV) testing only is indicated for vaginal discharge,  a co-test (HPV + cytology) should be ordered for abnormal bleeding, or suspicious findings on examination of the cervix

Treat the discharge based on what cause is identified. See bacterial vaginosiscandidiasischlamydiagonorrhoea, M. genitaliumtrichomoniasis, pelvic inflammatory disease (PID)

Treatment advice

  • Treat as per guidelines for diagnosis made after consideration of risk and assessment findings: initially presumptively, and then based on results when these become available
  • Intravaginal azoles and clindamycin can damage latex condoms
  • Avoid alcohol with metronidazole

Other immediate management

  • Consider other STI testing if assessment indicates risk or suspected or proven STI
  • Consider advice and referral if complicated presentation, systemically unwell or diagnosis uncertain
  • Provide patient with factsheet

  • No contact tracing is required for non-STIs
  • Contact tracing for chlamydiagonorrhoeatrichomoniasis and is a high priority and should be performed in all patients with confirmed infection

See Australasian Contract Tracing Manual for more information

If confirmed STI, follow up provides an opportunity to:

  • Confirm patient adherence with treatment and assess for symptom resolution
  • Confirm contact tracing procedures have been undertaken or offer more contact tracing support
  • Provide further sexual health education and prevention counselling

Even if all test results are negative, use the opportunity to:

  • Reassess for resolution or recurrence of symptoms
  • Educate about condom use, contraception, HIV PrEP/PEP, safe injecting practices, consent, and CST.
  • Vaccinate for hepatitis Ahepatitis B, human papillomavirus (HPV), if susceptible
  • Discuss and activate reminders for regular testing according to risk
  • Educate about normal genital skin care

For test of cure and retesting advice see:

100% of patients diagnosed with bacterial vaginosis are treated with an appropriate antibiotic regimen

Our Supporters

  • ASRHA
  • RACP
  • ASHHNA
  • Sexual and Reproductive Health Australia
  • RACGP
  • MSI Australia
  • AusPATH
  • Australian College of Nurse Practitioners
  • Scarlet Alliance, Australian Sex Workers Association